Association of eNOS polymorphisms (-786T>C, 4a4b, 894G>T) with colorectal cancer susceptibility in the Korean population

Gene

Volumn 512, Issue 2, 2013, Pages 275-281

  Jang, Moon Ju ^a   Jeon, Young Joo ^a   Kim, Jong Woo ^a   Chong, So Young ^a   Hong, Sung Pyo ^a   Oh, Doyeun ^a   Cho, Yun Kyung ^a   Chung, Ki Wha ^b   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

^b Kongju National University   (South Korea)

Author keywords

Colorectal cancer; Endothelial NOS (eNOS); Nitric oxide synthases (NOS); Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REPUBLIC OF KOREA;

EID: 84870386133     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.032     Document Type: Article

References (35)

1. Aleksandrova K., et al. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev. Res. 2011, 4:1873-1883.
2. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 1999, 31:577-596.
3. Cheon K.T., Choi K.H., Lee H.B., Park S.K., Rhee Y.K., Lee Y.C. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000, 178:351-360.
4. Choi B.M., Pae H.O., Jang S.I., Kim Y.M., Chung H.T. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Biol. 2002, 35:116-126.
5. Conde M.C., et al. Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol. Rep. 2006, 16:353-359.
6. Fatini C., et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am. Heart J. 2004, 147:516-521.
7. Fernandez M.L., et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb. Haemost. 2004, 92:413-418.
8. Gonzalez-Sanchez J.L., Martinez-Larrad M.T., Saez M.E., Zabena C., Martinez-Calatrava M.J., Serrano-Rios M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin. Chem. 2007, 53:91-97.
9. Hao Y., Montiel R., Huang Y. Endothelial nitric oxide synthase (eNOS) 894G>T polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2010, 124:809-813.
10. Hefler L.A., et al. Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol. Oncol. 2002, 86:134-137.
11. Hefler L.A., et al. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res. Treat. 2006, 98:151-155.
12. Hingorani A.D., et al. A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515-1520.
13. Jadeski L.C., Chakraborty C., Lala P.K. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int. J. Cancer 2003, 106:496-504.
14. Kim M.C., Kim C.S., Chung T.H., Park H.O., Yoo C.I. Metabolic syndrome, lifestyle risk factors, and distal colon adenoma: a retrospective cohort study. World J. Gastroenterol. 2011, 17:4031-4037.
15. Kong L., Dunn G.D., Keefer L.K., Korthuis R.J. Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin. Exp. Metastasis 1996, 14:335-343.
16. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 1998, 113:147-156.
17. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001, 2:149-156.
18. Lu J., et al. Promoter polymorphism (-786T>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 2006, 107:2245-2253.
19. Marsden P.A., et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992, 307:287-293.
20. Medeiros R., et al. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur. J. Cancer Prev. 2002, 11:343-350.
21. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329:2002-2012.
22. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
23. Riener E.K., et al. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol. Oncol. 2004, 93:686-690.
24. Rossi G.P., et al. The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients. J. Am. Coll. Cardiol. 2006, 48:1166-1174.
25. Tecder Unal M., et al. Endothelial nitric oxide synthase gene polymorphism in gastric cancer. Turk. J. Gastroenterol. 2010, 21:338-344.
26. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2832-2835.
27. Thomsen L.L., Miles D.W. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev. 1998, 17:107-118.
28. Veldman B.A., et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens. 2002, 20:2023-2027.
29. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., Wilcken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 1996, 2:41-45.
30. Wang X.L., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 1997, 17:3147-3153.
31. Wang X.L., Sim A.S., Wang M.X., Murrell G.A., Trudinger B., Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000, 471:45-50.
32. Xu W., Liu L.Z., Loizidou M., Ahmed M., Charles I.G. The role of nitric oxide in cancer. Cell Res. 2002, 12:311-320.
33. Yeh C.C., Santella R.M., Hsieh L.L., Sung F.C., Tang R. An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int. J. Cancer 2009, 124:1565-1571.
34. Yoshimura M., et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum. Genet. 1998, 103:65-69.
35. Ziche M., Morbidelli L. Molecular regulation of tumour angiogenesis by nitric oxide. Eur. Cytokine Netw. 2009, 20:164-170.